Evidence map›Paper›PMID 40256198›Full record

ArticleObesity pillars2025

Characterizing obesity: A qualitative study.

Tim Bober, Flor Cameron, Lane Alexander, J G Luiggi-Hernandez, David Rometo, Linda-Marie Lavenburg, Haley Grant, Emily Klawson, Autumn R Boyer, Kathleen M McTigue and 8 more

Abstract read
In one paragraph

Article in Obesity pillars, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Tim BoberDivision of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Flor CameronCenter for Biostatistics and Qualitative Methodology, Qualitative Core (CBQM Qual Core), University of Pittsburgh, Pittsburgh, PA, United States.
Lane AlexanderCenter for Biostatistics and Qualitative Methodology, Qualitative Core (CBQM Qual Core), University of Pittsburgh, Pittsburgh, PA, United States.
J G Luiggi-HernandezCenter for Biostatistics and Qualitative Methodology, Qualitative Core (CBQM Qual Core), University of Pittsburgh, Pittsburgh, PA, United States.
David RometoDivision of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Linda-Marie LavenburgDivision of Renal-Electrolyte, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Haley GrantSchool of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.
Emily KlawsonDivision of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Autumn R BoyerDivision of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Kathleen M McTigueDivision of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Julie Gouveia-PisanoPfizer Inc., New York, NY, United States.
Avani PatelPfizer Inc., New York, NY, United States.
Lisa TarasenkoPfizer Inc., New York, NY, United States.
Jannette EscobarPfizer Inc., New York, NY, United States.
Allison BrennerPfizer Inc., New York, NY, United States.
Scott M VouriPfizer Inc., New York, NY, United States.
Feng DaiPfizer Inc., New York, NY, United States.
Megan E HammCenter for Biostatistics and Qualitative Methodology, Qualitative Core (CBQM Qual Core), University of Pittsburgh, Pittsburgh, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of obesity among US adults has risen over the past several decades. In addition to bariatric surgery and behavioral weight management, several effective anti-obesity medications have emerged in the last ten years and become increasingly available. The goal of this qualitative study is to explore the perspectives of people with obesity (PwO), health professionals (HPs), and payors on obesity management and treatments. Methods: This was a 3-group interview study using a qualitative description approach with a target sample size of 40 PwO, 30 HPs who provide care to PwO (10 primary care providers; 10 providers specializing in obesity medicine; and 10 nurse practitioners, physician assistants, or dieticians/nutritionists), and 10 payors. PwO were eligible if they had a Body Mass Index (BMI) ≥30 kg/m Results: A total of 38 PwO, 30 HPs, and 6 payors were interviewed, with PwO interviews occurring from October 2023 to March 2024 and HP/payor interviews occurring from November 2023 to May 2024. The majority of participants in each group accepted the idea of obesity as a chronic disease and that discussing obesity and weight management was important in medical contexts; however, they also acknowledged that stigma around obesity negatively impacted PwO health and health care. All participants described a treatment landscape beginning with lifestyle interventions followed by pharmaceutical or surgical treatment options. Conclusion: This qualitative study of people with obesity, health professionals, and payors demonstrated current views of addressing and treating obesity in clinical settings. These findings could spur person-centered, less stigmatizing methods to craft plans for weight management.

Indexed as

Obesity treatmentPatientPayorProviderQualitative

Identifiers

PMID40256198
PMCPMC12008540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.